📄 $ABEO 10-Q — what changed
MD&A now says: "OVERVIEW We are a commercial-stage biopharmaceutical company developing cell and gene therapies for serious diseases."
📈 Full redline → https://www.formdelta.com/ticker/ABEO
@formdelta.bsky.social
@formdelta.bsky.social📄 $ABEO 10-Q — what changed
MD&A now says: "OVERVIEW We are a commercial-stage biopharmaceutical company developing cell and gene therapies for serious diseases."
📈 Full redline → https://www.formdelta.com/ticker/ABEO
@formdelta.bsky.social🔴 $ABEO — Seshadri Vishwas, Chief Executive Officer
SOLD: 19,608 shares @ $5.16
Total: $101K
Filed Sep 28, 2026 · 8:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/ABEO
@newsen.bsky.socialPomerantz Law Firm Probes Allegations Against Abeona Therapeutics Inc. Investors #USA #New_York #Pomerantz_LLP #Abeona_Therapeutics #ABEO
@newsen.bsky.socialPomerantz Law Firm Launches Investigation into Abeona Therapeutics and Potential Securities Fraud #United_States #New_York #Pomerantz_LLP #Abeona_Therapeutics #ABEO